quinapril has been researched along with Coronary Heart Disease in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.94) | 18.7374 |
| 1990's | 15 (44.12) | 18.2507 |
| 2000's | 18 (52.94) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, BV; Khan, QA; Lauten, WB; Lerakis, S; Parthasarathy, S; Rahman, ST; Rajagopalan, S | 1 |
| Hashizume, Y; Kurusu, T; Kuwata, M; Mochizuki, S; Onodera, T; Shimazu, Y; Takikawa, K; Taniguchi, I; Yamazaki, T; Yoshikawa, M | 1 |
| Dohi, Y; Fujii, T; Gomyo, Y; Hirai, Y; Kohno, N; Matsuura, W; Mito, S; Okimoto, T; Otsuka, M; Yamamoto, H | 1 |
| Guven, O; Guzelsoy, D; Sipahi, I; Tekin, G; Yigit, Z | 1 |
| Potaczek, DP; Szczeklik, A; Undas, A | 1 |
| Bucca, C; Cacciafesta, M; Di Gioacchino, C; Durante, M; Fimognari, FL; Lo Verde, A; Marigliano, V; Monteforte, G; Munizzi, MR; Piccirillo, G; Santagada, E; Tarantini, S; Viola, E | 1 |
| Carere, RG; Haber, HE; Henry, GC; Klibaner, MI; Lüscher, TF; Macaya, C; Mancini, GB; Mudra, H; O'Neill, BJ; Pepine, CJ; Pitt, B; Pucillo, AL; Uprichard, AC; Wargovich, TJ | 1 |
| Campbell, LW; Cashin-Hemphill, L; Chan, RC; Dinsmore, RE; Haber, HE; Holmvang, G; Klibaner, MI; Lees, RS; Pitt, B | 1 |
| Haber, HE; Mancini, GB; O'Neill, B; Pepine, CJ; Pitt, B; Schlaifer, JD; Wargovich, TJ | 1 |
| Pepine, C | 1 |
| Pepine, CJ | 1 |
| Gutteridge, C; Sayer, JW; Syndercombe-Court, D; Timmis, AD; Wilkinson, P | 1 |
| Bui, MN; Cannon, RO; Csako, G; Hathaway, L; Koh, KK; Panza, JA; Waclawiw, MA | 1 |
| Anderson, T | 1 |
| Haber, HE; Mancini, GB; O'Neill, BJ; Pepine, CJ; Pitt, B; Schlaifer, JD | 1 |
| Anderson, TJ; Charbonneau, F; Elstein, E; Haber, H | 1 |
| Riem, L | 1 |
| O'Neill, BJ | 1 |
| Hayashi, K; Kamiya, H; Kondo, J; Kosokabe, T; Matsui, H; Mukawa, H; Okumura, K; Sone, T; Suzuki, T; Tomida, T; Tsuboi, H; Tsuzuki, M | 1 |
| Buikema, H; Crijns, HJ; Grandjean, JG; Kingma, JH; Oosterga, M; Pinto, YM; van Gilst, WH; Voors, AA | 1 |
| Amouyel, P; Bauters, C; Bertrand, ME; Codron, V; Hermant, X; Lablanche, J; Mc Fadden, EP; Meurice, T; VanBelle, E | 1 |
| Ardissino, D; Gnecchi, M | 1 |
| Gomyo, Y; Hayashi, Y; Imazu, M; Kohno, N; Okimoto, T; Sekiguchi, Y; Shimohara, Y; Sumii, K; Tadehara, F; Toyofuku, M; Yamamoto, H; Yanagihara, K | 1 |
| Hayashi, Y; Hiyama, K; Imazu, M; Kohno, N; Sumii, K; Toyofyuku, M; Yamamoto, H | 1 |
| Hayakawa, T; Imai, H; Kamiya, H; Kondo, J; Mabuchi, Y; Matsui, H; Mukawa, H; Okumura, K; Sone, T; Tsuboi, H; Tsuzuki, M | 1 |
| Canter, D; Texter, M; Uprichard, AC | 1 |
| Bahrmann, H; Brunner, I; Bussmann, WD; Wittig, RA | 1 |
| Riegger, GA | 1 |
| Bussmann, WD; Goerke, S; Kaltenbach, M; Schneider, W | 1 |
2 review(s) available for quinapril and Coronary Heart Disease
| Article | Year |
|---|---|
Rationale for ACE inhibition as an anti-ischaemic therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cholesterol, LDL; Coronary Artery Disease; Coronary Disease; Endothelium, Vascular; Humans; Isoquinolines; Myocardial Ischemia; Quinapril; Randomized Controlled Trials as Topic; Survival Rate; Tetrahydroisoquinolines | 1998 |
Clinical data: AVERT and QUO VADIS.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; Coronary Angiography; Coronary Disease; Decision Making; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoquinolines; Myocardial Revascularization; Pyrroles; Quinapril; Randomized Controlled Trials as Topic; Tetrahydroisoquinolines; Treatment Outcome | 2000 |
18 trial(s) available for quinapril and Coronary Heart Disease
| Article | Year |
|---|---|
Effect of amlodipine on vascular responses after coronary stenting compared with an angiotensin-converting enzyme inhibitor.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Vessels; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Quinapril; Stents; Tetrahydroisoquinolines; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional; Vasodilator Agents | 2004 |
Long-term effects of quinapril with high affinity for tissue angiotensin-converting enzyme after coronary intervention in Japanese.
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Cause of Death; Coronary Disease; Coronary Restenosis; Disease-Free Survival; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Proportional Hazards Models; Quinapril; Risk Factors; Tetrahydroisoquinolines | 2004 |
Power spectral analysis of heart rate in elderly hypertensive subjects with or without silent coronary disease.
Topics: Aged; Algorithms; Amlodipine; Antihypertensive Agents; Case-Control Studies; Coronary Disease; Double-Blind Method; Electrocardiography; Heart Rate; Humans; Hypertension; Isoquinolines; Male; Metoprolol; Quinapril; Signal Processing, Computer-Assisted; Sympathetic Nervous System; Tetrahydroisoquinolines | 1996 |
Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Coronary Disease; Double-Blind Method; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Isoquinolines; Male; Middle Aged; Quinapril; Radiography; Tetrahydroisoquinolines; Vasomotor System | 1996 |
Baseline clinical and angiographic data in the Quinapril Ischemic Event (QUIET) Trial.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Coronary Angiography; Coronary Disease; Decision Trees; Double-Blind Method; Female; Humans; Isoquinolines; Lipids; Male; Middle Aged; Prospective Studies; Quinapril; Reproducibility of Results; Smoking; Tetrahydroisoquinolines | 1996 |
Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
Topics: Acetylcholine; Adenosine; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Endothelium, Vascular; Female; Humans; Isoquinolines; Male; Microcirculation; Middle Aged; Nitroglycerin; Pilot Projects; Quinapril; Tetrahydroisoquinolines; Vasodilator Agents | 1997 |
Angiotensin-converting enzyme inhibitors in patients with atherosclerosis and preserved left ventricular function: clinical outcomes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Coronary Disease; Endothelium, Vascular; Humans; Isoquinolines; Quinapril; Tetrahydroisoquinolines; Ventricular Function, Left | 1998 |
Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Coronary Disease; Coronary Vessels; Double-Blind Method; Endothelium, Vascular; Humans; Isoquinolines; Middle Aged; Nitroglycerin; Quinapril; Retrospective Studies; Smoking; Tetrahydroisoquinolines; Vasodilator Agents; Vasomotor System | 1999 |
Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)
Topics: Aged; Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Drug Therapy, Combination; Enalapril; Endothelium, Vascular; Female; Humans; Isoquinolines; Losartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines; Vasodilation | 2000 |
Effect of quinapril on intimal hyperplasia after coronary stenting as assessed by intravascular ultrasound.
Topics: Aged; Angioplasty, Balloon; Angiotensin-Converting Enzyme Inhibitors; Chi-Square Distribution; Coronary Angiography; Coronary Disease; Female; Humans; Hyperplasia; Isoquinolines; Male; Middle Aged; Prospective Studies; Quinapril; Recurrence; Stents; Tetrahydroisoquinolines; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional; Videotape Recording | 2001 |
Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia.
Topics: Aftercare; Aged; Angiotensin-Converting Enzyme Inhibitors; Combined Modality Therapy; Coronary Artery Bypass; Coronary Disease; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Test; Female; Humans; Isoquinolines; Male; Middle Aged; Premedication; Quinapril; Survival Analysis; Tetrahydroisoquinolines; Treatment Outcome | 2001 |
Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Constriction, Pathologic; Coronary Angiography; Coronary Disease; Double-Blind Method; Female; Gene Deletion; Genotype; Humans; Isoquinolines; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Quinapril; Recurrence; Risk Factors; Statistics, Nonparametric; Stents; Tetrahydroisoquinolines; Treatment Outcome | 2001 |
Quinapril with high affinity to tissue angiotensin-converting enzyme reduces restenosis after percutaneous transcatheter coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Humans; Isoquinolines; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Quinapril; Stents; Tetrahydroisoquinolines | 2001 |
Influence of angiotensinogen M253T gene polymorphism and an angiotensin converting enzyme inhibitor on restenosis after percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Coronary Disease; Coronary Restenosis; Female; Gene Frequency; Genotype; Humans; Isoquinolines; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Quinapril; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrahydroisoquinolines | 2002 |
Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele.
Topics: Aged; Alleles; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Body Mass Index; Coronary Disease; Coronary Restenosis; Humans; Isoquinolines; Middle Aged; Peptidyl-Dipeptidase A; Prodrugs; Quinapril; Risk Factors; Smoking; Stents; Tetrahydroisoquinolines | 2002 |
Clinical restenosis trials: a perspective from the pharmaceutical industry.
Topics: Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Coronary Disease; Humans; Isoquinolines; Quinapril; Recurrence; Research Design; Tetrahydroisoquinolines | 1992 |
[The angiotensin-converting enzyme inhibitor in the treatment of angina pectoris].
Topics: Administration, Oral; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Coronary Disease; Double-Blind Method; Electrocardiography; Exercise Test; Humans; Isoquinolines; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines; Time Factors | 1992 |
Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiomegaly; Cardiomyopathy, Dilated; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Isoquinolines; Long-Term Care; Male; Quinapril; Tetrahydroisoquinolines | 1991 |
14 other study(ies) available for quinapril and Coronary Heart Disease
| Article | Year |
|---|---|
Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Aspirin; Atorvastatin; Biphenyl Compounds; Cholesterol, LDL; Coronary Disease; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Interleukin-6; Irbesartan; Isoquinolines; Male; Middle Aged; Monocytes; Platelet Aggregation Inhibitors; Pyrroles; Quinapril; Tetrahydroisoquinolines; Tetrazoles | 2003 |
Effect of quinapril on the attenuated heart rate recovery of type 2 diabetic subjects without known coronary artery disease.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Heart Rate; Humans; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines | 2004 |
Interleukin-6 (IL-6)-174 G/C polymorphism--lack of association with inflammatory and haemostatic variables in patients with coronary heart disease treated with atorvastatin and quinapril.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; Biomarkers; Coronary Disease; Cytosine; Drug Therapy, Combination; Genotype; Guanine; Hemostasis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Polymorphism, Genetic; Pyrroles; Quinapril; Tetrahydroisoquinolines; Treatment Outcome | 2006 |
Circadian activity of the endogenous fibrinolytic system in stable coronary artery disease: effects of beta-adrenoreceptor blockers and angiotensin-converting enzyme inhibitors.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Circadian Rhythm; Coronary Disease; Female; Fibrinolysis; Hemostasis; Humans; Isoquinolines; Male; Middle Aged; Quinapril; Renin-Angiotensin System; Tetrahydroisoquinolines | 1998 |
Mechanism by which quinapril improves vascular function in coronary artery disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Flow Velocity; Brachial Artery; Coronary Disease; Echocardiography, Doppler, Pulsed; Electrocardiography; Endothelium, Vascular; Fibrinolysis; Humans; Isoquinolines; Male; Muscle, Smooth, Vascular; Nitric Oxide; Oxidative Stress; Plasminogen Activator Inhibitor 1; Quinapril; Tetrahydroisoquinolines; Treatment Outcome; Vasodilation | 1999 |
BANFF: an update.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Brachial Artery; Coronary Artery Bypass; Coronary Disease; Forearm; Humans; Isoquinolines; Quinapril; Tetrahydroisoquinolines | 1999 |
[Endothelium research. ACE inhibitor with high vascular affinity].
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Humans; Isoquinolines; Quinapril; Tetrahydroisoquinolines | 2000 |
[Prevention of ischemic complications. ACE inhibitor helps in endothelial crisis].
Topics: Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Endothelium, Vascular; Humans; Isoquinolines; Postoperative Complications; Quinapril; Tetrahydroisoquinolines | 1999 |
[Decreasing blood pressure and more: ACE inhibitor in coronary heart disease?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Disease; Endothelium, Vascular; Humans; Hypertension; Isoquinolines; Quinapril; Tetrahydroisoquinolines; Ventricular Remodeling | 2000 |
[Better endothelial function, fewer ischemic problems. An ACE inhibitor provides protection against ischemia].
Topics: Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Coronary Disease; Endothelium, Vascular; Humans; Isoquinolines; Quinapril; Tetrahydroisoquinolines | 2000 |
[Hypertensive patients with signs of coronary heart disease. An ACE inhibitor improves endothelial function].
Topics: Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Coronary Disease; Endothelium, Vascular; Humans; Hypertension; Isoquinolines; Quinapril; Randomized Controlled Trials as Topic; Tetrahydroisoquinolines; Treatment Outcome | 2001 |
[Effects of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): double-blind randomized trial].
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Angiography; Coronary Disease; Double-Blind Method; Humans; Isoquinolines; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Quinapril; Randomized Controlled Trials as Topic; Secondary Prevention; Stents; Tetrahydroisoquinolines | 2001 |
Worldwide clinical experience with ACE inhibitors: the role of quinapril. Proceedings of investigators' meeting. Marbella, Spain, June 10-11, 1989.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Coronary Disease; Humans; Isoquinolines; Quinapril; Tetrahydroisoquinolines | 1990 |
[Angiotensin-converting enzyme inhibitors in angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Coronary Disease; Dose-Response Relationship, Drug; Drug Evaluation; Exercise Test; Female; Humans; Isoquinolines; Male; Middle Aged; Physical Exertion; Quinapril; Tetrahydroisoquinolines | 1988 |